Alzamend Neuro
ALZN
ALZN
31 hedge funds and large institutions have $4.04M invested in Alzamend Neuro in 2022 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
57% less capital invested
Capital invested by funds: $9.41M → $4.04M (-$5.37M)
Holders
31
Holding in Top 10
–
Calls
$195K
Puts
$26K
Top Buyers
| 1 | +$62K | |
| 2 | +$35K | |
| 3 | +$32K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$31.4K |
| 5 |
Charles Schwab
San Francisco,
California
|
+$30K |
Top Sellers
| 1 | -$849K | |
| 2 | -$18K | |
| 3 | -$13K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$5.22K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$2K |